CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
_256_384.jpg)
Effective recovery at home begins with well-defined care plans that outline treatment protocols, recovery milestones, and monitoring requirements tailored to individual patient needs
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
The license is valid for five years, effective from April 9, 2026
Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems
Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
Subscribe To Our Newsletter & Stay Updated
